← Back to Screener
Retractable Technologies, Inc (RVP)
Price$0.70
Value ScoreA
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-32.08%
Price vs S&P 500 (4W)2.48%
VGM Score54.27
Market Capitalization$20.06M
All Metrics
Book Value / Share (Quarterly)$2.34
P/TBV (Annual)5.17x
Revenue Growth (3Y)-26.10%
Cash Flow / Share (Quarterly)$-0.25
Payout Ratio (TTM)2.78%
Price vs S&P 500 (YTD)-22.73%
Gross Margin (TTM)-2.13%
Net Profit Margin (TTM)-16.93%
EPS (TTM)$-0.21
10-Day Avg Trading Volume0.13M
EPS Excl Extra (TTM)$-0.21
Revenue Growth (5Y)-14.12%
EPS (Annual)$-0.42
Dividend / Share (Annual)$0.01
ROI (Annual)-16.63%
Gross Margin (Annual)4.83%
Net Profit Margin (5Y Avg)-9.95%
Cash / Share (Quarterly)$1.19
Revenue Growth QoQ (YoY)-13.47%
ROA (Last FY)-8.81%
Revenue Growth TTM (YoY)10.08%
EBITD / Share (TTM)$-0.43
ROE (5Y Avg)4.75%
Operating Margin (TTM)-55.90%
Cash Flow / Share (Annual)$-0.25
P/B Ratio0.29x
P/B Ratio (Quarterly)0.28x
Net Income / Employee (Annual)$-64,400
EV / Revenue (TTM)0.49x
Net Interest Coverage (TTM)-1.44x
ROA (TTM)-4.38%
EV / EBITDA (TTM)4.90x
EPS Incl Extra (Annual)$-0.42
Current Ratio (Annual)6.57x
Quick Ratio (Quarterly)4.17x
3-Month Avg Trading Volume0.07M
52-Week Price Return-0.12%
Revenue / Employee (TTM)$190,500
Tangible BV / Share (Quarterly)$1.00
P/S Ratio (Annual)0.52x
Asset Turnover (Annual)0.27x
52-Week High$1.14
Operating Margin (5Y Avg)-20.45%
EPS Excl Extra (Annual)$-0.42
CapEx CAGR (5Y)-52.01%
Tangible BV CAGR (5Y)-5.61%
26-Week Price Return-16.15%
Quick Ratio (Annual)4.78x
13-Week Price Return1.37%
Total Debt / Equity (Annual)0.02x
Current Ratio (Quarterly)5.74x
Enterprise Value$18.38M
Revenue / Share Growth (5Y)-12.27%
Asset Turnover (TTM)0.26x
Book Value / Share Growth (5Y)11.10%
Revenue / Employee (Annual)$196,200
Inventory Turnover (Annual)2.00x
Pretax Margin (Annual)-32.08%
Cash / Share (Annual)$1.24
3-Month Return Std Dev56.26%
Gross Margin (5Y Avg)20.62%
Net Income / Employee (TTM)$-32,300
ROE (Last FY)-16.89%
Net Interest Coverage (Annual)-0.87x
EPS Basic Excl Extra (Annual)$-0.42
P/FCF (TTM)2.13x
Receivables Turnover (TTM)6.02x
Total Debt / Equity (Quarterly)0.02x
EPS Incl Extra (TTM)$-0.21
Receivables Turnover (Annual)4.88x
ROI (TTM)-8.34%
Dividend Growth Rate (5Y)3.13%
P/S Ratio (TTM)0.54x
Pretax Margin (5Y Avg)-3.58%
Revenue / Share (Annual)$1.28
Tangible BV / Share (Annual)$0.96
Price vs S&P 500 (52W)-28.32%
Year-to-Date Return-11.79%
5-Day Price Return-4.74%
EPS Normalized (Annual)$-0.42
ROA (5Y Avg)1.94%
Net Profit Margin (Annual)-32.84%
Month-to-Date Return7.54%
Cash Flow / Share (TTM)$-0.13
EBITD / Share (Annual)$-0.38
Operating Margin (Annual)-50.37%
LT Debt / Equity (Annual)0.01x
ROI (5Y Avg)4.61%
LT Debt / Equity (Quarterly)0.01x
EPS Basic Excl Extra (TTM)$-0.21
P/TBV (Quarterly)2.56x
P/B Ratio (Annual)0.31x
Dividend / Share (TTM)$0.01
Inventory Turnover (TTM)2.02x
Pretax Margin (TTM)-16.91%
Book Value / Share (Annual)$2.48
Price vs S&P 500 (13W)-8.37%
Dividend Yield (TTM)1.15%
Beta1.26x
P/FCF (Annual)10.48x
Revenue / Share (TTM)$1.24
ROE (TTM)-8.45%
52-Week Low$0.60
vGradeA
gGradeD
mGradeC
vgmGradeC
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RVPRetractable Technologies, Inc | A | D | C | $0.70 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Retractable Technologies develops and manufactures safety-engineered syringes and injection systems for healthcare providers. Its branded products, including VanishPoint syringes and blood collection systems, emphasize needle safety features designed to reduce needlestick injuries. The company serves both U.S. and international markets with a focus on healthcare worker protection.